1  is a limitation of current state-of-the-art perfluorochemicals.

2                                              Perfluorochemicals are globally pervasive contaminants t

3 obin solutions of human or bovine origin and perfluorochemical-based emulsions are in advanced stages

4 rrying capacity of normal blood using liquid perfluorochemical emulsions combined with breathing high

5 recoverability, and hence recycleability, of perfluorochemicals from aqueous systems makes their rout

6 s the applications and beneficial effects of perfluorochemicals in cultured microbial, animal and pla

7                                              Perfluorochemical liquid has been used experimentally to

8 n the first human neonates were treated with perfluorochemical liquid, more than 500 human patients--

9                    We conclude that PLV with perfluorochemical liquids attenuates pulmonary sequelae

10 ion, similar to the effects of several other perfluorochemical liquids on normal lungs, pulmonary adm

11                            The properties of perfluorochemical liquids, particularly their high gas s

12 nds on the physicochemical properties of the perfluorochemical liquids.

13                               Treatment with perfluorochemical partial liquid ventilation (PLV: PP-5

14          Partial liquid ventilation with the perfluorochemical, perflubron, has been shown to improve

15 , 36 polychlorinated biphenyls (PCBs), and 7 perfluorochemicals (PFCs) in serum.

16 ethod [University of Wisconson solution (UW)/perfluorochemical plus O2] for pancreas preservation has

17 (TLM) (University of Wisconsin [UW] solution-perfluorochemical plus oxygen) of pancreas preservation.